Inovio Pharmaceuticals, Inc.
(NASDAQ : INO)

... ...
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.53%515.071.0%$788.47m
DHRDanaher Corp. 2.05%237.870.7%$564.64m
ABTAbbott Laboratories -0.09%112.850.8%$474.12m
ISRGIntuitive Surgical, Inc. -6.84%744.082.3%$430.78m
MDTMedtronic Plc -1.11%116.600.6%$406.12m
BSXBoston Scientific Corp. -1.33%37.021.0%$353.68m
DXCMDexCom, Inc. 0.71%370.127.8%$340.83m
BDXBecton, Dickinson & Co. -1.21%258.741.0%$296.55m
QDELQuidel Corp. 6.92%233.617.7%$231.59m
SYKStryker Corp. -1.46%240.051.3%$224.06m
ALGNAlign Technology, Inc. -1.79%534.086.4%$210.31m
AAgilent Technologies, Inc. -0.58%126.271.6%$194.84m
EWEdwards Lifesciences Corp. -1.95%85.530.4%$183.44m
BAXBaxter International, Inc. -0.58%79.551.8%$177.25m
OBLNObalon Therapeutics, Inc. 15.99%6.0210.5%$173.24m

Company Profile

Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company. It engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. The firm's drug candidates include SynCon immunotherapies which helps break the immune system’s tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.